HK1032360A1 - Combination therapy for the treatment of tumors. - Google Patents

Combination therapy for the treatment of tumors.

Info

Publication number
HK1032360A1
HK1032360A1 HK01103128A HK01103128A HK1032360A1 HK 1032360 A1 HK1032360 A1 HK 1032360A1 HK 01103128 A HK01103128 A HK 01103128A HK 01103128 A HK01103128 A HK 01103128A HK 1032360 A1 HK1032360 A1 HK 1032360A1
Authority
HK
Hong Kong
Prior art keywords
combination therapy
tumors
treatment
gastrin
combination
Prior art date
Application number
HK01103128A
Other languages
English (en)
Inventor
Philip C Gevas
Stephen Grimes
Stephen L Karr
Susan A Watson
Dov Michaeli
Original Assignee
Aphton Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corp filed Critical Aphton Corp
Publication of HK1032360A1 publication Critical patent/HK1032360A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK01103128A 1998-05-15 2001-05-03 Combination therapy for the treatment of tumors. HK1032360A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8568798P 1998-05-15 1998-05-15
PCT/US1999/010750 WO1999059628A2 (fr) 1998-05-15 1999-05-14 Therapie combinee pour le traitement de tumeurs

Publications (1)

Publication Number Publication Date
HK1032360A1 true HK1032360A1 (en) 2001-07-20

Family

ID=22193286

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103128A HK1032360A1 (en) 1998-05-15 2001-05-03 Combination therapy for the treatment of tumors.

Country Status (16)

Country Link
EP (1) EP1076561B1 (fr)
JP (1) JP2002515457A (fr)
KR (1) KR100699574B1 (fr)
CN (1) CN1216605C (fr)
AT (1) ATE291918T1 (fr)
AU (1) AU745749B2 (fr)
CA (1) CA2327439C (fr)
DE (1) DE69924483T2 (fr)
DK (1) DK1076561T3 (fr)
ES (1) ES2237103T3 (fr)
HK (1) HK1032360A1 (fr)
HU (1) HUP0101947A3 (fr)
PL (1) PL193109B1 (fr)
PT (1) PT1076561E (fr)
WO (1) WO1999059628A2 (fr)
ZA (1) ZA200005962B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091574A1 (en) * 2001-03-23 2003-05-15 Gevas Philip C. Combination treatment of pancreatic cancer
AU2002326356A1 (en) * 2001-07-09 2003-01-29 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
EP1528915A2 (fr) * 2002-07-03 2005-05-11 Aphton Corporation Vaccin liposomal
WO2004088326A2 (fr) 2003-03-28 2004-10-14 Aphton Corporation Dosages immunologiques pour la detection de l'hormone gastrine
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
EA201100464A1 (ru) * 2011-04-06 2012-10-30 Ооо "Метамакс" (Ооо "Метамах") Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
CA2929858C (fr) 2013-11-22 2022-03-29 CL BioSciences LLC Antagonistes de gastrine (p. ex., yf476, netazepide) pour le traitement et la prevention de l'osteoporose
CA3066756A1 (fr) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions et procedes pour induire des immunites humorales et cellulaires contre des tumeurs et un cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (fr) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Traitement par immunotherapie d'une tumeur, faisant appel a des anticorps monoclonaux de l'antigene 17-1a
ES2063912T3 (es) * 1989-01-24 1995-01-16 Aphton Corp Composiciones inmunogenicas frente a peptidos de gastrina.
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17

Also Published As

Publication number Publication date
EP1076561A2 (fr) 2001-02-21
KR20010052355A (ko) 2001-06-25
CA2327439C (fr) 2005-07-05
CN1303288A (zh) 2001-07-11
ATE291918T1 (de) 2005-04-15
DE69924483T2 (de) 2006-02-09
WO1999059628A2 (fr) 1999-11-25
ZA200005962B (en) 2002-01-24
HUP0101947A3 (en) 2001-12-28
PL344414A1 (en) 2001-11-05
CA2327439A1 (fr) 1999-11-25
DK1076561T3 (da) 2005-06-06
CN1216605C (zh) 2005-08-31
PL193109B1 (pl) 2007-01-31
WO1999059628A3 (fr) 2000-01-13
ES2237103T3 (es) 2005-07-16
AU745749B2 (en) 2002-03-28
KR100699574B1 (ko) 2007-03-23
HUP0101947A2 (hu) 2001-11-28
PT1076561E (pt) 2005-08-31
DE69924483D1 (de) 2005-05-04
AU3904599A (en) 1999-12-06
JP2002515457A (ja) 2002-05-28
EP1076561B1 (fr) 2005-03-30

Similar Documents

Publication Publication Date Title
MX9702415A (es) Extractos de cocoa antineoplastica y metodos para elaborar y usar los mismos.
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
EP0783299A4 (fr) Composes et compositions pour l'administration d'agents actifs
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MY113059A (en) Controlled-release dosage forms of azithromycin
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
GR3022321T3 (en) Use of il-4 to treat solid tumors
UA41355C2 (uk) Засіб для лікування нейро-сніду
MY164077A (en) Compositions and uses of et743 for treating cancer
HK1032360A1 (en) Combination therapy for the treatment of tumors.
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
PT944389E (pt) Composições purificadas de 10-propargil-10-desaza-aminopterina e métodos para a sua utilização no tratamento de tumores
GR3024157T3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
EP1006793A4 (fr) Compositions pour traiter l'arythmie et procedes de traitement
AP1896A (en) The method of treating cancer
WO1992018536A3 (fr) Procede de detection et de localisation de tissus comprenant des recepteurs de neurokinine 1
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
AU4042795A (en) Treatment of non-small cell lung carcinoma
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
IL126158A0 (en) Method for treating substance abuse
HU9301719D0 (en) Medical preparatives for treatment of b-cell tumours
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи
UA33715A (uk) Спосіб лікування залізодефіцитних анемій у вагітних
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190513